45 studies found for:    CONCERT
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
2 Terminated Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
3 Terminated An Extension of the CONCERT Protocol (DIM18)
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
4 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
5 Unknown  A Clinical Trial Of Two Educational Strategies In Cardiovascular Health In Child Population
Conditions: Obesity;   Cardiovascular Diseases
Intervention: Other: Didactic Concerts
6 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cyclosporine;   Drug: etoposide;   Drug: vincristine sulfate;   Radiation: radiation therapy
7 Active, not recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Conditions: Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions: Drug: CTP-499;   Drug: Placebo
8 Completed Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
Condition: Stage 3 Chronic Kidney Disease
Interventions: Drug: CTP-499;   Drug: placebo
9 Withdrawn Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
10 Withdrawn Study of Epratuzumab in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Epratuzumab
11 Unknown  Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Procedure: Ex Vivo Immunotherapy;   Drug: Ex vivo immunotherapy
12 Completed Drug Combination on Exercise Performance at High Altitude
Condition: Acute Mountain Sickness
Interventions: Drug: ambrisentan and theophylline;   Drug: placebo
13 Withdrawn Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.
Conditions: Newly Diagnosed Diffuse Large B-Cell Lymphoma;   Intermediate (Burkitt-Like) Lymphoma
Intervention: Drug: R-HCVAD and R-MC
14 Recruiting Study of a Community Based Approach to Control Cardiovascular Risk Factors in India
Conditions: Hypertension;   Diabetes;   Smoking;   Cardiovascular Diseases
Intervention: Behavioral: Community health worker
15 Recruiting Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Condition: Venous Ulcers
Intervention: Procedure: Blood Draw
16 Active, not recruiting Correlation of Mesalamine Pharmacokinetics With Local Availability
Condition: Local Drug Concentration in Gastrointestinal Tract
Interventions: Drug: Pentasa 500 mg capsule x 2 with 240 mL water; single dose;   Drug: Apriso 375 mg capsule x 3 with 240 mL water; single dose;   Drug: Lialda 1200 mg tablet x 1 with 240 mL water; single dose;   Drug: Asacol 400 mg tablet x 1 with 240 mL water; single dose
17 Completed Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
Condition: Nasopharyngeal Carcinoma
Intervention:
18 Completed
Has Results
Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: doxycycline;   Drug: placebo gel
19 Active, not recruiting The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Leuprolide Acetate (Eligard®);   Radiation: Intensity-Modulated Radiotherapy
20 Recruiting Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
Conditions: Diabetes Mellitus Type I;   Ketoacidosis
Interventions: Drug: Insulin withdrawal;   Drug: Norditropin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years